InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Dier Mardi, Chief Financial Officer. Officer active across 5 companies, notably Adamas Pharmaceuticals Inc. Cumulatively, 13 filings have been published. Breakdown: 1 buy · 7 sells. Total volume traded: €1.3m. Activity tracked since 2 June 2021. The latest transaction was disclosed on 10 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
258 shares@ US$323.0417.1% of flowCommon StockSEC:0001628280-25-012369:0
3,784 shares0Common StockSEC:0001628280-25-011407:0
1,187 shares@ US$325.8982.9% of flowCommon StockSEC:0001628280-25-010508:0
5,556 shares@ US$18.00100.0% of flowCommon StockSEC:0001209191-23-028864:0
Ideal exit: 3 Feb 2024 (T+270)
1,629 shares@ US$40.169.1% of flowCommon StockSEC:0001209191-22-053884:0
3,484 shares@ US$38.2218.7% of flowCommon StockSEC:0001209191-22-053647:0
20,000 shares0Common StockSEC:0001209191-22-050670:0
534 shares@ US$66.620.0013% mcap6.0% of flowCommon StockSEC:0001209191-22-015833:0
3,477 shares@ US$82.790.010% mcap47.0% of flowCommon StockSEC:0001209191-21-060504:0
3,477 shares@ US$82.7934.0% of flowCommon StockSEC:0001209191-21-060504
5,000 shares0Common StockSEC:0001328143-21-000056:0
5,000 shares0Common StockSEC:0001328143-21-000056
13,750 sharesCommon StockSEC:0001209191-16-094212:0
13 of 13 declarations
About Dier Mardi
Mardi Dier is the Chief Financial Officer and Executive Vice President at Adamas Pharmaceuticals Inc and Ultragenyx Pharmaceutical Inc. He is responsible for the financial management of these companies, including financial planning, risk management, and compliance. His financial expertise is essential to support the growth and strategy of both companies.
